1. Home
  2. KVYO vs RGEN Comparison

KVYO vs RGEN Comparison

Compare KVYO & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Klaviyo Inc. Series A

KVYO

Klaviyo Inc. Series A

HOLD

Current Price

$19.70

Market Cap

5.4B

Sector

N/A

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$126.27

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVYO
RGEN
Founded
2012
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
8.1B
IPO Year
2023
1995

Fundamental Metrics

Financial Performance
Metric
KVYO
RGEN
Price
$19.70
$126.27
Analyst Decision
Strong Buy
Buy
Analyst Count
22
11
Target Price
$35.55
$173.09
AVG Volume (30 Days)
5.3M
797.4K
Earning Date
01-01-0001
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
35.29
286.96
EPS
N/A
0.86
Revenue
$1,234,019,000.00
$141,236,000.00
Revenue This Year
$24.47
$13.89
Revenue Next Year
$19.66
$15.00
P/E Ratio
N/A
$143.33
Revenue Growth
31.63
35.10
52 Week Low
$15.53
$102.97
52 Week High
$39.66
$175.77

Technical Indicators

Market Signals
Indicator
KVYO
RGEN
Relative Strength Index (RSI) 47.53 29.70
Support Level $15.53 $113.07
Resistance Level $34.18 $132.51
Average True Range (ATR) 1.34 7.12
MACD 0.48 -0.51
Stochastic Oscillator 73.21 32.18

Price Performance

Historical Comparison
KVYO
RGEN

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: